Pharmaceutical Temperature Controlled Packaging Solutions Market Size Anticipa...

Pharmaceutical Temperature Controlled Packaging Solutions Estimated USD 945.2 Million by 2030

Status: Published Category: Healthcare Packaging Insight Code: 5048 Format: PDF / PPT / Excel

The global pharmaceutical temperature-controlled packaging solutions market was valued at USD 578.9 million in 2022 and is predicted to reach around USD 945.2 million by 2030, growing at a 6.30% CAGR from 2022 to 2030.

Pharmaceutical Temperature Controlled Packaging Market Statistics 2022 To 2030

Unlock Infinite Advantages: Subscribe to Annual Membership

The pharmaceutical temperature-controlled packaging solutions market has experienced significant growth in recent years, driven by the increasing demand for temperature-sensitive medications and the need for effective packaging solutions to maintain product integrity. This market overview will provide insights into the key factors driving the market, industry trends, and the competitive landscape.

The global pharmaceutical industry has witnessed a surge in the development of temperature-sensitive drugs, including vaccines, biologics, and specialty medications. These products require strict temperature control throughout the supply chain to ensure their efficacy and safety. As a result, pharmaceutical companies are actively seeking packaging solutions that can maintain the desired temperature range during storage and transportation. The temperature-controlled pharmaceutical solution packaging market encompasses a wide range of products, including insulated shipping containers, temperature monitoring devices, phase change materials, and thermal packaging accessories. These solutions are designed to provide thermal insulation, temperature monitoring, and protection against temperature excursions, ensuring the integrity of the pharmaceutical products.

One of the key drivers for this market is the increasing adoption of biologics and personalized medicines, which are highly temperature-sensitive. Biologics, such as vaccines and protein-based therapeutics, require strict temperature control to maintain their stability and effectiveness. The growing prevalence of chronic diseases and the demand for personalized treatments are fueling the demand for temperature-controlled pharmaceutical packaging solutions. Another significant factor driving the market growth is the stringent regulatory guidelines imposed by regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These guidelines emphasize the importance of maintaining product quality, efficacy, and patient safety throughout the supply chain. As a result, pharmaceutical companies are investing in advanced packaging solutions that comply with these regulations and help them meet quality standards.

The temperature-controlled pharmaceutical solution packaging market is characterized by intense competition, with several key players operating globally. These companies focus on developing innovative, cost-effective packaging solutions to gain a competitive edge. Additionally, partnerships and collaborations with pharmaceutical manufacturers and logistics providers are becoming increasingly common to offer comprehensive temperature-controlled solutions. Industry trends indicate a shift towards sustainable packaging solutions. With growing environmental concerns, pharmaceutical companies are looking for eco-friendly packaging materials and technologies that reduce carbon footprint. Furthermore, advancements in technology, such as the Internet of Things (IoT) and data analytics, enable real-time temperature monitoring and provide valuable insights into the supply chain, ensuring better control and visibility.

Strategic Analysis of Regional Dependencies and Supply Chain Adaptability

The pharmaceutical industry's supply chain, although characterized by a higher degree of global integration compared to other sectors, often faces the risk of material shortages due to companies relying on a single region for critical sourcing. This vulnerability is particularly pronounced during local conflicts and natural disasters. Notably, approximately 40% of pharmaceutical trade occurs within specific regions, which is slightly lower than the average of 50% observed in other industries. To provide specific examples, 86% of streptomycin sold in North America and 96% of chloramphenicol sold in the European Union are sourced from China, underscoring the concentration of dependence on a single origin.

Pharmaceutical Temperature Controlled Packaging Market Revenue, By Region, 2019 To 2030
North America has emerged as the dominant market for temperature-controlled packaging solutions in the pharmaceutical industry, capturing a significant market share. This growth can be attributed to the increasing demand from the healthcare sector. The region experiences a strong need for transporting vaccines and drugs and conducting clinical trials, leading to substantial growth in the temperature-controlled packaging sector. Notably, North America, particularly the United States, houses numerous renowned market participants actively developing advanced technologies and efficient processes for cold chain systems. However, the current strain of coronavirus has disrupted the global pharmaceutical supply chain, posing a significant obstacle for key market players. China, known as the "world's factory," has played a crucial role in this disruption. The widespread lockdowns, slowdowns in product manufacturing, shortage of raw materials, and labour scarcities have had a domino effect on the international supply chain, specifically impacting North America's temperature-controlled pharmaceutical packaging market. As a result, this market is at risk due to the challenges posed by the global pandemic and its impact on the supply chain.

Companies can adopt strategies to diversify their material procurement to mitigate the risks associated with single-source dependencies and other supply chain vulnerabilities. By expanding their sourcing options, organizations can reduce exposure to potential disruptions. This can be achieved through various approaches, such as diversifying suppliers domestically, exploring nearshoring opportunities to secure supplies from neighbouring regions, or even offshore outsourcing to new locations that offer favourable conditions. By diversifying their sourcing locations, companies can enhance their resilience and ensure a more secure and reliable supply of inputs.

The pharmaceutical temperature-controlled packaging solutions industry in the Asia Pacific region is expected to exhibit the highest compound annual growth rate (CAGR) in the coming years. This growth can be attributed to the increasing demand for insulated packaging from countries like Japan, China, and India. The Asia Pacific region is anticipated to experience significant growth due to the current impact of the coronavirus pandemic and the restrictions on the export of several active pharmaceutical ingredients (APIs) from India. Additionally, the market is being stimulated by the limitations imposed on many generic drug manufacturers based in the United States, whose supply chains heavily rely on Chinese suppliers. These factors collectively contribute to the growth prospects of the pharmaceutical temperature-controlled packaging solutions industry in the Asia Pacific region.

In the pharmaceutical industry, the decision to relocate operations is frequently motivated by factors beyond economic considerations. Governments often prioritize national security and self-sufficiency, leading them to encourage domestic production. A notable example is the Indian government's initiative to enhance the domestic manufacturing of bulk drugs and medical devices through a substantial $1.3 billion stimulus plan. Similarly, the Austrian government is partnering with Sandoz International to invest in antibiotic production at the company's Kundl facility, ensuring a sufficient supply within the country. These instances exemplify how government involvement and investments are aimed at strengthening local production capabilities and securing critical supplies in the pharmaceutical sector.

Unlocking Value: Reusable Temperature-Controlled Packaging for a Circular Economy

Certain products in the industry uphold the highest standards set by the sector, characterized by their utilization of premium-grade components and exhibiting exceptional durability. These products are designed to be reusable, showcasing their long-lasting nature and sustainability. By adhering to rigorous quality measures, these offerings ensure that customers receive products that not only meet but exceed industry benchmarks, delivering superior performance and reliability.

  • No Sweat Gel Packs are specifically designed to maintain the dryness and cool temperature of moisture and temperature-sensitive products. They feature a non-woven outer layer that effectively minimizes condensation, preserving the integrity of the transported or stored products. These gel packs are available in various sizes and weights, offering flexibility to meet the specific requirements of different applications. With their innovative design, No Sweat Gel Packs provide reliable moisture control and optimal cooling to ensure the freshness and quality of the enclosed items.
  • Eco-Friendly Gel Packs are crafted from Kraft paper, making them environmentally conscious alternatives to conventional gel packs. When disposed of through the regular waste stream, these gel packs generate reduced pollution compared to standard varieties. The Kraft paper outer layer of the gel packs has the added benefit of absorbing some condensation that may occur during the warming process, thereby maintaining the dryness of the packaged products more effectively than traditional gel packs. Similar to other gel pack options, the eco-friendly variant is available in a diverse range of sizes and weights to cater to various packaging needs. Combining sustainability, moisture control, and versatility, Eco-Friendly Gel Packs offer an environmentally responsible solution for preserving product quality.
  • Segmented Gel Packs are specifically engineered to provide enhanced coverage and protection for products during transportation. These gel packs are meticulously designed to ensure the optimal conditioning of the enclosed items, maintaining their desired temperature range. Available in various sizes, weights, and types of foil, these gel packs offer flexibility to cater to diverse packaging requirements. The segmentation of the gel packs allows for better distribution of the gel material, ensuring consistent cooling or insulation across the entire surface area of the product. This segmented design helps to minimize temperature fluctuations and create a more controlled environment within the packaging.

For Instance,

  • In March 2022, Cold Chain Technologies, LLC, a prominent global provider of thermal packaging solutions for temperature-sensitive products and Aurora Capital Partners portfolio company, completed the acquisition of Packaging Technology Group, LLC (PTG). PTG is a leading supplier of environmentally friendly and curbside-recyclable thermal packaging solutions specifically tailored for the life sciences industry. This strategic acquisition further solidifies Cold Chain Technologies' commitment to providing sustainable, eco-friendly packaging solutions. The integration of PTG's renowned TRUEtemp Naturals® Line, initially launched in 2018, enhances Cold Chain Technologies' ability to deliver exceptional time-temperature performance at pharmaceutical-grade levels while ensuring a packaging solution that is 100% curbside recyclable and environmentally conscious. Using PTG's innovative solutions, customers can significantly reduce the life sciences sector's carbon footprint by millions of pounds annually and minimize landfill waste.

Temperature-Controlled Packaging: Vital Component of the Cold Chain Across Diverse Industries

Medical and pharmaceutical 

The pharmaceutical industry, experiencing rapid growth and stringent regulations, has played a pivotal role in fostering the advancement of innovative and high-performance packaging solutions. The maintenance of precise temperatures during transportation and storage is of utmost importance to ensure the effectiveness and safety of medications, vaccines, and various other pharmaceutical products. Through the utilization of appropriate temperature-controlled packaging, a wide range of pharmaceuticals, including biological samples, can be securely shipped and stored, maintaining the required temperature conditions until they are ready for use. These temperature-controlled packaging solutions have become indispensable in preserving the integrity and potency of pharmaceutical products throughout their supply chain journey.

Food & Beverage

The food and beverage industry is a significant user of temperature-controlled packaging, as approximately 40% of food products require refrigeration. With the increasing popularity of meal kit services and grocery delivery, there is a growing demand for reliable packaging solutions that can effectively preserve the freshness and quality of perishable food items until they are delivered to the end consumer. Temperature-controlled packaging is crucial in maintaining the optimal temperature conditions required for perishable food products, ensuring they remain safe for consumption. These packaging solutions help to prevent spoilage, bacterial growth, and degradation of food quality during transportation and storage. The need for high-quality temperature-controlled packaging becomes even more critical as the food and beverage industry embraces innovative delivery models and e-commerce platforms. By utilizing such packaging solutions, companies can meet the increasing expectations of consumers who seek convenient and reliable food delivery services while ensuring that the freshness and safety of perishable products are preserved throughout the supply chain.


The transportation and storage of high-purity chemicals pose unique challenges due to their sensitivity to temperature fluctuations. Temperature-controlled packaging plays a crucial role in safeguarding these temperature-sensitive chemicals during transit to minimize degradation and maintain their integrity. Temperature-controlled packaging ensures that specific temperature ranges are maintained consistently, protecting the chemicals from adverse conditions that could compromise their quality or stability. This is particularly important when shipping these chemicals to manufacturing plants, agricultural facilities, and research institutions, where their specific properties are crucial for various processes and experiments. Companies can confidently transport high-purity chemicals by employing temperature-controlled packaging solutions, knowing that the necessary temperature conditions are maintained throughout the journey. This helps prevent degradation, maintain product efficacy, and preserve the integrity of these sensitive chemicals, ensuring they arrive at their destination in optimal condition.

For Instance,

  • In December 2022, in response to the increasing demand for environmentally friendly packaging solutions for temperature-sensitive pharmaceuticals, Sonoco ThermoSafe, a division of Sonoco, a leading producer of cold chain packaging for temperature assurance, is expanding its Orion Rental packaging program in the United Kingdom. The Orion reusable rental packaging initiative provides UK healthcare organizations with access to a wide range of biologics, vaccines, clinical supplies, and other healthcare products that require specific temperature control during transportation. By extending this program, Sonoco ThermoSafe aims to meet the growing need for sustainable packaging options in the pharmaceutical industry while ensuring the safe and reliable transport of temperature-sensitive healthcare products.

Crisis and Resilience: Analysing the COVID-19 Impact on the Temperature-Controlled Pharmaceuticals Solution Packaging Market

The COVID-19 pandemic has had a significant and transformative impact on the temperature-controlled pharmaceutical packaging market. As the world grapples with the challenges posed by the global health crisis, the demand for temperature-controlled packaging solutions for pharmaceuticals has skyrocketed. The pandemic has highlighted the critical importance of maintaining pharmaceutical products' efficacy, safety, and integrity, especially vaccines and other temperature-sensitive medications.

One of the key effects of COVID-19 on the temperature-controlled pharmaceutical packaging market has been the unprecedented surge in vaccine demand. As pharmaceutical companies raced to develop and distribute vaccines to combat the virus, the need for reliable temperature-controlled packaging solutions became paramount. Vaccines, particularly mRNA-based ones, require strict temperature control to maintain efficacy. This has created a significant market opportunity for temperature-controlled packaging providers to ensure the safe transportation and storage of vaccines at the required temperature ranges. Moreover, the pandemic has disrupted global supply chains, causing logistical challenges and delays in the delivery of pharmaceutical products. Lockdown measures, travel restrictions, and increased border controls have posed significant hurdles in the timely distribution of medications. In response, the temperature-controlled packaging market has adapted to these challenges by providing innovative solutions that ensure the stability and quality of pharmaceuticals during transit. Advanced temperature monitoring technologies, insulation materials, and cold chain management systems have been developed to address the specific requirements of pharmaceutical transportation during the pandemic.

Another notable effect of the pandemic on the temperature-controlled pharmaceutical packaging market has been the increased focus on ensuring supply chain resilience. The vulnerability of global supply chains has been exposed, prompting pharmaceutical companies to re-evaluate and strengthen their supply chain strategies. This includes investing in robust temperature-controlled packaging solutions to mitigate risks and ensure the uninterrupted availability of critical medications. By implementing temperature-controlled packaging systems, pharmaceutical companies can better manage the storage and transportation of temperature-sensitive products, reducing the likelihood of spoilage, product degradation, and wastage.

Comparative Landscape Analysis of the Temperature-Controlled Pharmaceuticals Solution Packaging Market 

The temperature-controlled pharmaceutical solution packaging market refers to the industry that provides packaging solutions for pharmaceutical products that require strict temperature control to maintain their efficacy and safety. This market has witnessed significant growth in recent years due to the increasing demand for temperature-sensitive drugs and the need to ensure their quality during storage and transportation. The comparative landscape of the temperature-controlled pharmaceutical solution packaging market involves analysing the key players and their market positions, strategies, product offerings, and competitive advantages.

Major Key Players

Pelican Biothermal, Sonoco, Sofrigam SA Ltd., Cryopak, Inmark Packaging, Cold Chain Technologies, VA-Q-Tec AG, Envirotainer Ltd., and American Aerogel Corporation

For Instance,

  • On March 10, 2023, Cryopak, a renowned cold chain packaging and temperature monitoring device provider announced a strategic partnership with M. Chasen & Son, Inc. to establish Chasen Fiber Technologies. This collaboration aims to bolster Cryopak's commitment to environmentally-friendly shipping solutions by leveraging the expertise and resources of both companies. Chasen Fiber Technologies will focus on developing innovative fiber-based technologies to enhance the efficiency and sustainability of the shipping industry.

Segments Covered in the Report

By Product

  • Reusable Solutions
  • Single Use Solutions

By Application

  • Temperature-Sensitive Pharmaceuticals
  • Vaccines
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

About The Author

Swapna is a seasoned research consultant with expertise in conducting and analysing complex research projects across various industries. With a deep passion for knowledge discovery and a commitment to delivering actionable insights, Swapna has successfully collaborated with numerous organisations to help them make informed decisions and drive strategic growth. Swapna has developed a strong track record of designing and implementing research methodologies that generate high-quality data and meaningful results. Through careful attention to detail and a meticulous approach. She possesses a diverse skill set, including proficiency in data collection techniques, statistical analysis, and data visualisation. With expertise in both qualitative and quantitative research methods, Swapna is adept at crafting research frameworks tailored to the unique needs and objectives of each project. By leveraging advanced analytical tools and software, Swapna transforms complex data sets into concise and impactful reports that drive actionable insights.

Swapna excels in working closely with clients, understanding their research goals, and translating those goals into effective research strategies. Through clear and concise communication, Swapna ensures that research findings are presented in a manner that is easily understandable and actionable, enabling clients to make informed decisions and drive positive outcomes. She stays updated with the latest advancements in the field, constantly refining her skills and knowledge to provide cutting-edge research solutions. As a research consultant, Swapna is dedicated to helping organizations uncover valuable insights, solve complex problems, and achieve their strategic objectives. With a passion for research excellence and a commitment to client satisfaction, She is a trusted partner in driving evidence-based decision-making and empowering businesses to thrive in today\'s dynamic market landscape.


The global pharmaceutical temperature controlled packaging solutions market was valued at US$ 618.6 million in 2019 and predicted to reach US$ 945.2 million by 2030.

North America is predicted to hit major share in the global pharmaceutical temperature-controlled packaging solutions market

Reusable temperature controlled pharmaceutical solution dominated the global market.

McKinsey & Company, Deloitte, White paper, and News and articles